82187-6Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detectionActive
Term Description
This assay detects the presence of nucleic acid sequences from the Streptococcus pneumoniae DNA in cerebrospinal fluid (CSF) using PCR and non-probe based detection methods, such as melt curve analysis. This term was created for, but is not limited in use to, BioFire's FilmArray Meningitis/Encephalitis Panel, which is intended for the detection and identification of nucleic acids from multiple bacteria, viruses, and yeast directly from CSF obtained via lumbar puncture from individuals with signs and/or symptoms of meningitis and/or encephalitis.
Source: Regenstrief LOINC
Part Description
LP14410-2 Streptococcus pneumoniae
Streptococcus pneumoniae are gram-positive cocci that are nonmotile and nonsporulating and usually require complex culture media. Older streptococcal cultures, beyond the most active growth period (the logarithmic phase), sometimes lose their gram-positive staining characteristics. S. pneumoniae are part of the normal respiratory tract flora. Disease usually results due to the acquisition of a new strain following a change in the normal flora, often due to a preceding virus. S. pneumonaie causes otitis media, sinusitis and pneumonia in the middle ear, sinuses or lungs, respectively. Meningitis can occur by bloodstream invasion from the lungs or by extension of otitis media or sinusitis to the meninges. Bacteremia can result in osteomyelitis (infection of bones) or arthritis (of joints). Most bacterial pneumonia occurring after the neonatal period is caused by S. pneumoniae. Pneumococcal pneumonia is seen most commonly in elderly or immunosuppressed individuals. In the United States, it is most prevalent in winter. Diagnosis is usually based on a sputum Gram stain and culture although blood or cerebrospinal fluid may be cultured. While penicillin has been the standard treatment, some strains have proven resistant to penicillin and multiple antibiotics. A vaccine exists. [NCBI Books:NBK7611]
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Streptococcus pneumoniae DNA
- Property
- PrThr
- Time
- Pt
- System
- CSF
- Scale
- Ord
- Method
- Non-probe.amp.tar
Additional Names
- Short Name
- S pneum DNA CSF Ql NAA+non-probe
- Display Name
- S. pneumoniae DNA NAA+non-probe Ql (CSF)
- Consumer Name Alpha
- Streptococcus pneumoniae, Spinal fluid
Example Answer List LL744-4
Source: Regenstrief Institute
Answer | Code | Score | Answer ID |
---|---|---|---|
Detected | LA11882-0 | ||
Not detected | LA11883-8 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.56
- Last Updated
- Version 2.63
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
82180-1 | Meningitis+Encephalitis pathogens panel - Cerebral spinal fluid by NAA with non-probe detection |
Language Variants Get Info
- zh-CNChinese (China)
- 肺炎链球菌 DNA:
存在情况或阈值: 时间点: 脑脊液: 序数型: 非探针法.基因扩增.靶向 - fr-CAFrench (Canada)
- Streptococcus pneumoniae , ADN:
Présence-Seuil: Temps ponctuel: LCR: Ordinal: Non-sonde.amplification de cible - fr-FRFrench (France)
- Streptococcus pneumoniae ADN:
Présence/Seuil: Ponctuel: Liquide céphalorachidien: Qualitatif: Non-PCR amplification de cible - it-ITItalian (Italy)
- Streptococcus pneumoniae DNA:
PrThr: Pt: LCS: Ord: Non-sonda.amp.tar - es-MXSpanish (Mexico)
- ADN de Streptococo pneumoniae:
Presencia o umbral: Punto temporal: Fluído espinal cerebral: Ordinal: Amplificación de ácidos nucleicos con detección sin sonda - es-ESSpanish (Spain)
- Streptococcus pneumoniae ADN:
PrThr: Punto temporal: Líquido Cefalorraquideo: Ord: Amplificación del objetivo no basado en sonda
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=82187-6
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright